Trial Design For NeurogesX’s Qutenza Pain Patch Should Exclude Opioids, Committee Suggests
Executive Summary
The Anesthetic and Analgesic Drug Products Advisory Committee unanimously recommended against approving the patch for pain associated with HIV neuropathy, but suggested the company employ a different trial design which uses a different comparator and excludes patients on concomitant opioids to gather more confirmatory evidence.